Unlock instant, AI-driven research and patent intelligence for your innovation.

A cd133 antagonistic polypeptide and its derivatives and applications

A derivative and antagonistic technology, applied in the field of biotechnology and biomedicine, to achieve huge social and economic benefits, and promote the effect of apoptosis

Active Publication Date: 2022-07-01
SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

With the increasing research reports on tumor stem cell markers of colorectal cancer, CD44 / CD133 is currently a commonly used marker of tumor stem cells in colorectal cancer, and the high expression of CD44 / CD133 is a risk factor affecting the prognosis of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A cd133 antagonistic polypeptide and its derivatives and applications
  • A cd133 antagonistic polypeptide and its derivatives and applications
  • A cd133 antagonistic polypeptide and its derivatives and applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Example 1: Panning, amplification, purification, sequencing and synthesis of CD133 antagonistic polypeptide HL12-CP5 were performed.

[0048] The purpose of this example is to screen and obtain positive phages that specifically bind to CD133, and then by amplifying and purifying the positive phages, extracting phage single-stranded DNA (ssDNA) for sequencing, analyzing and comparing the obtained sequences, and finally synthesizing high-purity phages The antagonistic polypeptide HL12-CP5.

[0049] details as follows:

[0050] 1. Establishment of 293T cell line with permanent high expression of CD133: 293T-CD133 + / +

[0051] ①Choose vigorously growing luminescent human 293T cells, and culture them at 5 × 10 cells one day before transfection. 5 Cells / well, seeded in 6-well plates, and after the second day of culture, the cell confluence was 60%;

[0052] ②Transfection was carried out on the second day. Using one culture well of a 6-well plate as a unit, 3 μg of plasmid...

Embodiment 2

[0070] Example 2 Enzyme-linked immunosorbent assay to detect the binding of phage monoclonal to CD133

[0071] First, a single clone of HL12-CP5 phage was picked, inoculated into LB medium containing ER2738, and cultured at 37°C with shaking at 230 rpm for 7 hours. Centrifuge at 5000rpm for 15min at room temperature, collect the supernatant and store at 4°C. 293T wild-type cells, 293TCD133 + / + Cells, HCT-116 cells and HT-29 cells were plated at 5 × 10 per well 3 were seeded in 96-well plates and cultured for 24 hours. The next day, the cell culture medium was discarded, and blocking solution (DMEM+5%BSA) was added to each well to block for 2 hours. After discarding the blocking solution, 100 μL of phage dilution (1:100) was added to each well for 2 hours. Then wash with PBST (PBS+0.1% Tween-20) 3 times for 5 min each time to remove unbound phage. 100 μL of diluted (1:5000) peroxidase-linked anti-M13 phage antibody (purchased from GE) was added to each well, and allowed to...

Embodiment 3

[0072] Example 3 HL12-CP5 can significantly inhibit the proliferation of colorectal cancer cells HCT-116

[0073] ①The colorectal cancer cells HCT-116 were divided into 5×10 3 Cells / well were inoculated into 96-well cell culture plates with a medium volume of 200 μL per well, cultured for 24 hours, and then starved overnight;

[0074] ②Add different concentration gradients (100μM, 10μM, 1μM, 0.1μM, 0.01μM, 0.001μM) of HL12-CP5 polypeptide and culture for 24 hours, 48 ​​hours and 72 hours respectively;

[0075] ③ Add 20 μL of MTT working solution to each well, and continue to culture in a carbon dioxide incubator for 4 hours;

[0076] ④ Discard the supernatant in the culture plate, add 150 μL DMSO (dimethyl sulfoxide), shake for 10 minutes, select a wavelength of 490 nm on a microplate reader for detection, and draw a cell growth curve.

[0077] In the preliminary work of the inventor's laboratory, it was found that the colorectal cancer cell HCT-116 highly expressed CD133 by...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a CD133 antagonistic polypeptide and its derivatives and applications, and specifically discloses a CD133 antagonistic polypeptide: the amino acid residue sequence of the CD133 antagonistic polypeptide HL12-CP5 is shown in SEQ ID No: 1, the binding peptide and Its derivatives can bind to CD133 in vitro, block its downstream signaling pathway by binding to CD133, thereby inhibiting the proliferation of colorectal cancer cells, promoting the apoptosis of colorectal cancer cells, and providing effective small molecule drugs for the treatment of colorectal cancer, etc. It can be widely used in the fields of medicine and biology.

Description

technical field [0001] The present invention relates to the fields of biotechnology and biomedicine, in particular, the present invention relates to a colorectal cancer target CD133 receptor antagonistic polypeptide HL12-CP5 and its derivatives and applications. Background technique [0002] 1.1. Colorectal cancer [0003] Colorectal cancer (CRC) is one of the most common malignant tumors in the world. According to the report of the International Agency for Research on Cancer (IARC) of the World Health Organization, the incidence of colorectal cancer ranks third in malignant tumors after lung cancer and breast cancer, and the mortality rate ranks third in malignant tumors after lung cancer, liver cancer and gastric cancer. Tumor No. 4. There are significant differences in the geographical distribution of colorectal cancer incidence in the world, and the incidence in Europe and the United States is higher than that in Asia. The incidence of CRC in China was 29 / 100,000, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/08C12N15/11C07K16/00G01N33/68G01N33/574A61K38/10A61P35/00
CPCC07K7/08C07K16/00G01N33/6872G01N33/57484G01N33/57419G01N33/57446A61P35/00A61K38/00G01N2333/70596
Inventor 黄来强代小勇刘可为董璐吴佳敏冯春燕
Owner SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV